This is a Validated Antibody Database (VAD) review about Rhesus mon.. TNFRSF13B, based on 3 published articles (read how Labome selects the articles), using TNFRSF13B antibody in all methods. It is aimed to help Labome visitors find the most suited TNFRSF13B antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TNFRSF13B synonym: NF-AT; tumor necrosis factor receptor superfamily member 13B; transmembrane activator; tumor necrosis factor receptor superfamily, member 13B

BioLegend
rat monoclonal (1A1)
  • flow cytometry; human; fig 1a
BioLegend TNFRSF13B antibody (BioLegend, 1A1) was used in flow cytometry on human samples (fig 1a). Blood (2018) ncbi
rat monoclonal (1A1)
  • flow cytometry; human; loading ...; fig s1c
BioLegend TNFRSF13B antibody (Biolegend, 311912) was used in flow cytometry on human samples (fig s1c). Eur J Immunol (2018) ncbi
rat monoclonal (1A1)
  • flow cytometry; human; loading ...; fig 4c
In order to characterize B and T cells from patients with thrombocytopenia, BioLegend TNFRSF13B antibody (BioLegend, 311906) was used in flow cytometry on human samples (fig 4c). Haematologica (2016) ncbi
Articles Reviewed
  1. Lee L, Draper B, Chaplin N, Philip B, Chin M, Galas Filipowicz D, et al. An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma. Blood. 2018;131:746-758 pubmed publisher
  2. den Hartog G, van Osch T, Vos M, Meijer B, Savelkoul H, van Neerven R, et al. BAFF augments IgA2 and IL-10 production by TLR7/8 stimulated total peripheral blood B cells. Eur J Immunol. 2018;48:283-292 pubmed publisher
  3. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed publisher